COST-EFFECTIVENESS ANALYSIS OF REMDESIVIR FOR THE TREATMENT OF COVID-19 HOSPITALIZED ADULTS IN MEXICO

被引：0
|
作者：
Ponce-de-Leon, A. [1 ]
Azamar-Alonso, A. [2 ]
Silva-Sanchez, F. [2 ]
Chirino-Sprung, R. [2 ]
Dominguez-Esquivel, V [3 ]
Rajme-Lopez, S. [1 ]
机构：
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[2] Gilead Sci Mexico S RL CV, Mexico City, DF, Mexico
[3] HS Estudios Farmacoeconom, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSC41
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [31] Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US
    Goswami, Hardik
    Alsumali, Adnan
    Jiang, Yiling
    Schindler, Matthias
    Duke, Elizabeth R.
    Cohen, Joshua
    Briggs, Andrew
    Puenpatom, Amy
    PHARMACOECONOMICS, 2022, 40 (07) : 699 - 714
  • [32] Optimal control and comprehensive cost-effectiveness analysis for COVID-19
    Asamoah, Joshua Kiddy K.
    Okyere, Eric
    Abidemi, Afeez
    Moore, Stephen E.
    Sun, Gui-Quan
    Jin, Zhen
    Acheampong, Edward
    Gordon, Joseph Frank
    RESULTS IN PHYSICS, 2022, 33
  • [33] Cost-effectiveness analysis of vaccination against COVID-19 in China
    Zhou, Huixuan
    Ding, Ningxin
    Han, Xueyan
    Zhang, Hanyue
    Liu, Zeting
    Jia, Xiao
    Yu, Jingjing
    Zhang, Wei
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [34] COVID-19 Vaccines Cost-Effectiveness Analysis: A Scenario for Iran
    Vaezi, Atefeh
    Meysamie, Alipasha
    VACCINES, 2022, 10 (01)
  • [35] COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey
    Hagens, Arnold
    Inkaya, Ahmet Cagkan
    Yildirak, Kasirga
    Sancar, Mesut
    van der Schans, Jurjen
    Sancar, Aylin Acar
    Unal, Serhat
    Postma, Maarten
    Yegenoglu, Selen
    VACCINES, 2021, 9 (04)
  • [36] Cost-effectiveness analysis of diagnostic strategies for COVID-19 in Iran
    Rahmanzadeh, F.
    Malekpour, N.
    Faramarzi, A.
    Yusefzadeh, H.
    BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [37] Cost-effectiveness analysis of diagnostic strategies for COVID-19 in Iran
    F Rahmanzadeh
    N Malekpour
    A Faramarzi
    H Yusefzadeh
    BMC Health Services Research, 23
  • [38] REMDESIVIR USE IN HOSPITALIZED COVID-19 PATIENTS
    Said, Mohamed Ziad-M
    Ramirez, Claudia
    Almaguer, Angelica
    Emeaba, Ndiya
    Vazquez-Suarez, Amando A.
    Nieto, Fernando Loyola
    Girn, Tarunveer
    Mamki, Patience
    Burton, Diamond
    Valencia, Ired
    Silva-Llanas, Viana
    Texidor-Enchautegui, Jovana
    Gonzalez, Jesus Salvador
    Bhalla, Sushen
    Martini-Medina, Daniel
    Canete-Cruz, Ailine
    Akinwale, David
    Hussaini, Najia
    Varon, Joseph
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 208 - 208
  • [39] The costs of COVID-19 and the cost-effectiveness of testing
    Gonzalez Lopez-Valcarcel, Beatriz
    Vallejo-Torres, Laura
    APPLIED ECONOMIC ANALYSIS, 2021, 29 (85): : 77 - 89
  • [40] Effectiveness of tocilizumab in the treatment of hospitalized adults COVID-19 A systematic review and meta-analysis
    Zhang, Jing
    Chen, Chun
    Yang, Yi
    Yang, Jin
    MEDICINE, 2022, 101 (09) : E28967
12345